Literature DB >> 23127511

Metabolism and breast cancer risk: frontiers in research and practice.

Ruth E Patterson1, Cheryl L Rock, Jacqueline Kerr, Loki Natarajan, Simon J Marshall, Bilge Pakiz, Lisa A Cadmus-Bertram.   

Abstract

Fifty years ago the causes of cancer were largely unknown. Since then, it has become clear that a strong relationship exists between obesity and many cancers, particularly postmenopausal breast cancer. A major challenge in understanding the link between obesity and cancer risk has been elucidating the biological basis underlying the association. Although this remains unresolved, the main candidate systems linking adiposity and cancer risk are insulin and the insulin-like growth factor-1 axis, endogenous reproductive hormones, and chronic inflammation. Our purpose is to provide a mechanistic overview of the hypothesized relationship between diet, physical activity, and obesity with breast cancer risk and progression. In addition, we will provide examples of recently funded randomized clinical trials examining metabolic risk factors in relation to breast cancer risk and survival. Additional research is warranted to validate the strength and consistency of the relationships among diet, these biomarkers, and breast cancer risk. As these relationships become clearer, future studies will be needed to develop effective intervention programs to prevent breast cancer and improve cancer prognosis by promoting a healthy lifestyle.
Copyright © 2013 Academy of Nutrition and Dietetics. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23127511      PMCID: PMC3557584          DOI: 10.1016/j.jand.2012.08.015

Source DB:  PubMed          Journal:  J Acad Nutr Diet        ISSN: 2212-2672            Impact factor:   4.910


  71 in total

Review 1.  Anti-inflammatory diets for obesity and diabetes.

Authors:  Barry Sears
Journal:  J Am Coll Nutr       Date:  2009-08       Impact factor: 3.169

2.  Postdiagnosis change in bodyweight and survival after breast cancer diagnosis.

Authors:  Patrick T Bradshaw; Joseph G Ibrahim; June Stevens; Rebecca Cleveland; Page E Abrahamson; Jessie A Satia; Susan L Teitelbaum; Alfred I Neugut; Marilie D Gammon
Journal:  Epidemiology       Date:  2012-03       Impact factor: 4.822

3.  Researchers probe targeted agents' clinical potential for cancer prevention.

Authors:  Tracy Hampton
Journal:  JAMA       Date:  2010-01-13       Impact factor: 56.272

4.  Role of insulin secretion and sensitivity in the evolution of type 2 diabetes in the diabetes prevention program: effects of lifestyle intervention and metformin.

Authors:  Abbas E Kitabchi; Marinella Temprosa; William C Knowler; Steven E Kahn; Sarah E Fowler; Steven M Haffner; Reuben Andres; Christopher Saudek; Sharon L Edelstein; Richard Arakaki; Mary Beth Murphy; Harry Shamoon
Journal:  Diabetes       Date:  2005-08       Impact factor: 9.461

5.  Fasting insulin and outcome in early-stage breast cancer: results of a prospective cohort study.

Authors:  Pamela J Goodwin; Marguerite Ennis; Kathleen I Pritchard; Maureen E Trudeau; Jarley Koo; Yolanda Madarnas; Warren Hartwick; Barry Hoffman; Nicky Hood
Journal:  J Clin Oncol       Date:  2002-01-01       Impact factor: 44.544

6.  Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults.

Authors:  Eugenia E Calle; Carmen Rodriguez; Kimberly Walker-Thurmond; Michael J Thun
Journal:  N Engl J Med       Date:  2003-04-24       Impact factor: 91.245

Review 7.  Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis.

Authors:  Eric L Ding; Yiqing Song; Vasanti S Malik; Simin Liu
Journal:  JAMA       Date:  2006-03-15       Impact factor: 56.272

8.  Nutrition and physical activity during and after cancer treatment: an American Cancer Society guide for informed choices.

Authors:  Jean K Brown; Tim Byers; Colleen Doyle; Kerry S Coumeya; Wendy Demark-Wahnefried; Lawrence H Kushi; Anne McTieman; Cheryl L Rock; Noreen Aziz; Abby S Bloch; Barbara Eldridge; Kathryn Hamilton; Carolyn Katzin; Amy Koonce; Julie Main; Connie Mobley; Marion E Morra; Margaret S Pierce; Kimberly Andrews Sawyer
Journal:  CA Cancer J Clin       Date:  2003 Sep-Oct       Impact factor: 508.702

9.  Recursive SVM feature selection and sample classification for mass-spectrometry and microarray data.

Authors:  Xuegong Zhang; Xin Lu; Qian Shi; Xiu-Qin Xu; Hon-Chiu E Leung; Lyndsay N Harris; James D Iglehart; Alexander Miron; Jun S Liu; Wing H Wong
Journal:  BMC Bioinformatics       Date:  2006-04-10       Impact factor: 3.169

View more
  18 in total

1.  Risk of breast cancer recurrence associated with carbohydrate intake and tissue expression of IGFI receptor.

Authors:  Jennifer A Emond; John P Pierce; Loki Natarajan; Laarni R Gapuz; John Nguyen; Barbara A Parker; Nissi M Varki; Ruth E Patterson
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-04-22       Impact factor: 4.254

2.  Effects of diet composition on weight loss, metabolic factors and biomarkers in a 1-year weight loss intervention in obese women examined by baseline insulin resistance status.

Authors:  Cheryl L Rock; Shirley W Flatt; Bilge Pakiz; Elizabeth L Quintana; Dennis D Heath; Brinda K Rana; Loki Natarajan
Journal:  Metabolism       Date:  2016-07-25       Impact factor: 8.694

3.  Objective Assessment of Physical Activity: Classifiers for Public Health.

Authors:  Jacqueline Kerr; Ruth E Patterson; Katherine Ellis; Suneeta Godbole; Eileen Johnson; Gert Lanckriet; John Staudenmayer
Journal:  Med Sci Sports Exerc       Date:  2016-05       Impact factor: 5.411

4.  Elevated GH/IGF-I promotes mammary tumors in high-fat, but not low-fat, fed mice.

Authors:  Manuel D Gahete; José Córdoba-Chacón; Daniel D Lantvit; Rosa Ortega-Salas; Rafael Sanchez-Sanchez; Francisco Pérez-Jiménez; José López-Miranda; Steven M Swanson; Justo P Castaño; Raúl M Luque; Rhonda D Kineman
Journal:  Carcinogenesis       Date:  2014-08-01       Impact factor: 4.944

5.  Increased chemopreventive effect by combining arctigenin, green tea polyphenol and curcumin in prostate and breast cancer cells.

Authors:  Piwen Wang; Bin Wang; Seyung Chung; Yanyuan Wu; Susanne M Henning; Jaydutt V Vadgama
Journal:  RSC Adv       Date:  2014-08-05       Impact factor: 3.361

6.  Recruitment strategies, design, and participant characteristics in a trial of weight-loss and metformin in breast cancer survivors.

Authors:  Ruth E Patterson; Catherine R Marinac; Loki Natarajan; Sheri J Hartman; Lisa Cadmus-Bertram; Shirley W Flatt; Hongying Li; Barbara Parker; Jesica Oratowski-Coleman; Adriana Villaseñor; Suneeta Godbole; Jacqueline Kerr
Journal:  Contemp Clin Trials       Date:  2015-12-17       Impact factor: 2.226

7.  Hip and Wrist Accelerometer Algorithms for Free-Living Behavior Classification.

Authors:  Katherine Ellis; Jacqueline Kerr; Suneeta Godbole; John Staudenmayer; Gert Lanckriet
Journal:  Med Sci Sports Exerc       Date:  2016-05       Impact factor: 5.411

Review 8.  The Influence of Energetic Factors on Biomarkers of Postmenopausal Breast Cancer Risk.

Authors:  Heather K Neilson; Shannon M Conroy; Christine M Friedenreich
Journal:  Curr Nutr Rep       Date:  2013-12-15

9.  Does cancer risk increase with HbA1c, independent of diabetes?

Authors:  J C de Beer; L Liebenberg
Journal:  Br J Cancer       Date:  2014-03-27       Impact factor: 7.640

10.  Frequency and Circadian Timing of Eating May Influence Biomarkers of Inflammation and Insulin Resistance Associated with Breast Cancer Risk.

Authors:  Catherine R Marinac; Dorothy D Sears; Loki Natarajan; Linda C Gallo; Caitlin I Breen; Ruth E Patterson
Journal:  PLoS One       Date:  2015-08-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.